EPO logo
EPO boards of appeal decisions
homepage => search & index => boards of appeal decisions
Search mask List of updates
Date of decision 20 December 1999
Case number G 0001/98 - EBA
Application number 91810144.5
IPC A01N63/00
Proceedings Language EN
Title of the application Anti-pathogenically effective compositions comprising lytic peptides and hydrolytic enzymes
Applicant name Novartis AG
Opponent name -
Headnote
I. A claim wherein specific plant varieties are not individually claimed is not excluded from patentability under Article 53(b), EPC even though it may embrace plant varieties.

II. When a claim to a process for the production of a plant variety is examined, Article 64(2) EPC is not to be taken into consideration.

III. The exception to patentability in Article 53(b), 1st half-sentence, EPC applies to plant varieties irrespective of the way in which they were produced. Therefore, plant varieties containing genes introduced into an ancestral plant by recombinant gene technology are excluded from patentability.

Articles and Rules EPC . Art 52
. Art 53(b)
. Art 54
. Art 64(2)
. R 23b
Keywords
Claims comprising but not identifying plant varieties
Plant varieties as products of recombinant gene technology
Article 64(2) EPC not relevant for examination of product claims
Cited Decisions G 0005/83
T 0049/83
T 0292/85
T 0320/87
T 0361/87
T 0019/90
T 0356/93
Catchwords:
-

get the full pdf
 

EPO Home Page | Recent updates | Request info | Send comments | Index
Patent information on the internet


Copyright © 1997-2000 European Patent Office . All Rights Reserved.
E-mail: EPO Mail Distribution